Oppenheimer Maintains Outperform on Pharvaris, Raises Price Target to $42
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Justin Kim has maintained an 'Outperform' rating on Pharvaris (NASDAQ:PHVS) and raised the price target from $38 to $42.
September 06, 2024 | 12:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer has reaffirmed its 'Outperform' rating for Pharvaris and increased the price target to $42, indicating confidence in the company's future performance.
The increase in price target from $38 to $42 by Oppenheimer suggests a positive outlook on Pharvaris' future performance. The 'Outperform' rating indicates that the analyst expects the stock to perform better than the market average, which could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100